HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of angioplasty in acute myocardial infarction.

Abstract
The role of primary angioplasty versus thrombolytic therapy for the treatment of coronary thrombosis has been the subject of recent randomised trials. They have shown a higher early patency rate after angioplasty with no differences in later patency. Recurrent ischaemia was more frequent after thrombolysis, but the one study that examined myocardial salvage showed no difference. There were fewer intracerebral bleeds in the angioplasty group, but owing mostly to much higher than usual stroke occurrence in the thrombolysis group. With less than 800 patients in all the studies, no final conclusions can yet be drawn about effects on mortality and larger studies are needed. Primary angioplasty is an option when operators are skilled and the procedure can be done quickly.
AuthorsA Ross
JournalAustralian and New Zealand journal of medicine (Aust N Z J Med) Vol. 23 Issue 6 Pg. 753-5 (Dec 1993) ISSN: 0004-8291 [Print] Australia
PMID8141719 (Publication Type: Comparative Study, Journal Article)
Topics
  • Angioplasty, Balloon, Coronary (adverse effects)
  • Cerebrovascular Disorders (etiology)
  • Humans
  • Myocardial Infarction (drug therapy, therapy)
  • Randomized Controlled Trials as Topic
  • Thrombolytic Therapy (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: